Manhattan West Asset Management’s Pfizer PFE Stock Holding History

Manhattan West Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.74M	Buy	113,888 +6,369	+6%	+$167K	0.46%	54
2026 Q1	$3.02M	Buy	107,519 +16,303	+18%	+$434K	0.59%	46
2025 Q4	$2.27M	Buy	91,216 +4,726	+5%	+$119K	0.46%	55
2025 Q3	$2.2M	Buy	86,490 +3,758	+5%	+$92.8K	0.47%	58
2025 Q2	$2.01M	Buy	82,732 +5,862	+8%	+$137K	0.46%	58
2025 Q1	$1.95M	Buy	76,870 +14,365	+23%	+$376K	0.5%	56
2024 Q4	$1.66M	Sell	62,505 -9,108	-13%	-$247K	0.45%	63
2024 Q3	$2.07M	Buy	71,613 +4,753	+7%	+$139K	0.54%	59
2024 Q2	$1.87M	Sell	66,860 -15,214	-19%	-$419K	0.51%	63
2024 Q1	$2.28M	Buy	82,074 +12,724	+18%	+$353K	0.55%	58
2023 Q4	$2M	Buy	69,350 +4,507	+7%	+$136K	0.56%	53
2023 Q3	$2M	Buy	64,843 +15,956	+33%	+$564K	0.62%	45
2023 Q2	$1.79M	Buy	48,887 +13,275	+37%	+$517K	0.67%	45
2023 Q1	$1.45M	Buy	35,612 +5,028	+16%	+$217K	0.63%	43
2022 Q4	$1.57M	Buy	30,584 +1,402	+5%	+$67.2K	0.8%	31
2022 Q3	$1.28M	Buy	29,182 +3,402	+13%	+$165K	0.79%	34
2022 Q2	$1.35M	Buy	25,780 +1,883	+8%	+$96K	0.82%	31
2022 Q1	$1.24M	Buy	+23,897	New	+$1.24M	0.67%	35

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Manhattan West Asset Management's PFE Position: Q2 2026 in Review

Manhattan West Asset Management increased its Pfizer (PFE) stake by 5.9% in Q2 2026, buying an estimated $167K and bringing the position to 113,888 shares worth $2.74M. The position accounts for 0.46% of the portfolio, ranked #54.

Manhattan West Asset Management first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.02M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Manhattan West Asset Management held 113,888 shares of Pfizer worth $2.74M as of Q2 2026.
Manhattan West Asset Management bought 6,369 Pfizer shares in Q2 2026, an estimated $167K.
Pfizer made up 0.46% of Manhattan West Asset Management's portfolio in Q2 2026, its #54 holding.
Manhattan West Asset Management first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
Manhattan West Asset Management's Pfizer position peaked at $3.02M in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Manhattan West Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.